BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26779999)

  • 1. Brain somatic mutations in MTOR leading to focal cortical dysplasia.
    Lim JS; Lee JH
    BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
    Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
    Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.
    Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N
    Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
    Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
    Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
    Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
    JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II.
    Zhao S; Li Z; Zhang M; Zhang L; Zheng H; Ning J; Wang Y; Wang F; Zhang X; Gan H; Wang Y; Zhang X; Luo H; Bu G; Xu H; Yao Y; Zhang YW
    Exp Mol Med; 2019 Jul; 51(7):1-11. PubMed ID: 31337748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy.
    Kim JK; Cho J; Kim SH; Kang HC; Kim DS; Kim VN; Lee JH
    J Clin Invest; 2019 Oct; 129(10):4207-4223. PubMed ID: 31483294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.
    Leventer RJ; Scerri T; Marsh AP; Pope K; Gillies G; Maixner W; MacGregor D; Harvey AS; Delatycki MB; Amor DJ; Crino P; Bahlo M; Lockhart PJ
    Neurology; 2015 May; 84(20):2029-32. PubMed ID: 25878179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Somatic Mutations in MTOR Disrupt Neuronal Ciliogenesis, Leading to Focal Cortical Dyslamination.
    Park SM; Lim JS; Ramakrishina S; Kim SH; Kim WK; Lee J; Kang HC; Reiter JF; Kim DS; Kim HH; Lee JH
    Neuron; 2018 Jul; 99(1):83-97.e7. PubMed ID: 29937275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
    Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
    Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAergic Interneuron and Neurotransmission Are mTOR-Dependently Disturbed in Experimental Focal Cortical Dysplasia.
    Zhong S; Zhao Z; Xie W; Cai Y; Zhang Y; Ding J; Wang X
    Mol Neurobiol; 2021 Jan; 58(1):156-169. PubMed ID: 32909150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
    D'Gama AM; Geng Y; Couto JA; Martin B; Boyle EA; LaCoursiere CM; Hossain A; Hatem NE; Barry BJ; Kwiatkowski DJ; Vinters HV; Barkovich AJ; Shendure J; Mathern GW; Walsh CA; Poduri A
    Ann Neurol; 2015 Apr; 77(4):720-5. PubMed ID: 25599672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.
    D'Gama AM; Woodworth MB; Hossain AA; Bizzotto S; Hatem NE; LaCoursiere CM; Najm I; Ying Z; Yang E; Barkovich AJ; Kwiatkowski DJ; Vinters HV; Madsen JR; Mathern GW; Blümcke I; Poduri A; Walsh CA
    Cell Rep; 2017 Dec; 21(13):3754-3766. PubMed ID: 29281825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal malformations of cortical development: new vistas for molecular pathogenesis.
    Lim KC; Crino PB
    Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy.
    Winawer MR; Griffin NG; Samanamud J; Baugh EH; Rathakrishnan D; Ramalingam S; Zagzag D; Schevon CA; Dugan P; Hegde M; Sheth SA; McKhann GM; Doyle WK; Grant GA; Porter BE; Mikati MA; Muh CR; Malone CD; Bergin AMR; Peters JM; McBrian DK; Pack AM; Akman CI; LaCoursiere CM; Keever KM; Madsen JR; Yang E; Lidov HGW; Shain C; Allen AS; Canoll PD; Crino PB; Poduri AH; Heinzen EL
    Ann Neurol; 2018 Jun; 83(6):1133-1146. PubMed ID: 29679388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic variants in new candidate genes identified in focal cortical dysplasia type II.
    Zhang Z; Gao K; Liu Q; Zhou J; Li X; Lang N; Liu M; Wang T; Zhang J; Wang H; Dong Y; Ji T; Wang S; Liu X; Jiang Y; Cai L; Wu Y
    Epilepsia; 2020 Apr; 61(4):667-678. PubMed ID: 32216069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA.
    Lee WS; Stephenson SEM; Howell KB; Pope K; Gillies G; Wray A; Maixner W; Mandelstam SA; Berkovic SF; Scheffer IE; MacGregor D; Harvey AS; Lockhart PJ; Leventer RJ
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1338-1344. PubMed ID: 31353856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATORopathies: The role of amino acid regulatory gene mutations in epilepsy and cortical malformations.
    Iffland PH; Carson V; Bordey A; Crino PB
    Epilepsia; 2019 Nov; 60(11):2163-2173. PubMed ID: 31625153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.